Dr. Modabbernia is currently a psychiatry resident and graduate student in neuroscience at the Icahn School of Medicine at Mount Sinai (ISMMS). He has a diverse research background in the field of psychiatry and clinical neuroscience and more than 50 publications and 3000 citations in peer-reviewed psychiatry and neuroscience journals. Dr. Modabbernia received his MD from Tehran University Medical Sciences in Iran. After finishing medical school, he spent four years studying the effect of novel psychotherapeutics with anti-inflammatory and glutamatergic properties on various neuropsychiatric disorders such as schizophrenia, autism and major depression. During his early postdoctoral years and through working with patients with mental illness, he became increasingly interested in how early life experiences affect the risk for mental illness. Subsequently, he moved to New York City where he started working as a postdoctoral fellow in the laboratory of Professor Abraham Reichenberg at the ISMMS. There, in collaboration with multiple international groups he investigated the role of early life risk factors for neuropsychiatric disorders including schizophrenia, autism, and Tourette’s syndrome. In 2016, he started psychiatry residency and graduate school in neuroscience at the ISMMS. Currently, working with Professor Sophia Frangou, Dr. Modabbernia is studying the interplay between brain development, environment, and psychopathology in youth.
